Fungus research funding accounts for lower than 3% of the infectious disease budgets of main worldwide funders (at least in the UK and US), which reflects the dearth of funding purposes submitted. Our ability to deal with fungal illnesses is severely hampered by a worldwide lack of scientists and clinicians working on this space. This lack of capacity is particularly severe in the creating world, which suffers the greatest burden of illness. It is telling that there is not a single vaccine towards fungal infections in current medical use. Worryingly, drug resistance is increasing and there a